Literature DB >> 23998436

Utility of the Rey-15 recognition trial to detect invalid performance in a forensic neuropsychological sample.

Chelsea L Morse1, Kara Douglas-Newman, Steven Mandel, Thomas Swirsky-Sacchetti.   

Abstract

The current study sought to address the utility of the Rey Fifteen Item Test (Rey-15), with the use of a combined score [recall correct + (recognition correct - false positives)], to distinguish between valid and invalid performance among a sample of litigating persons referred for neuropsychological evaluation. Scores on the Rey-15 were analyzed across four comparison groups: (1) litigating persons with evidence of invalid performance (n = 29), (2) litigating persons with valid performance (n = 63), (3) learning-disabled patients (n = 36), and (4) a mixed clinical neuropsychological sample not involved in litigation (n = 54). A Rey-15 combined cutoff score of < 21 yielded the highest sensitivity (70%) and specificity (92.8%) rates. If the Rey-15 is to be used in clinical practice to detect invalid performance, the recognition trial with combined score < 21 should be used. Findings support the use of the combined Rey-15 score in place of the previously used recall Rey-15 score to improve sensitivity and specificity rates for detection of invalid performance in litigating neuropsychological referrals.

Entities:  

Mesh:

Year:  2013        PMID: 23998436     DOI: 10.1080/13854046.2013.832385

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  1 in total

1.  A novel methodology for the objective ascertainment of psychic and existential damage.

Authors:  Santo Davide Ferrara; Viviana Ananian; Eric Baccino; Rafael Boscolo-Berto; Ranieri Domenici; Claudio Hernàndez-Cueto; George Mendelson; Gian Aristide Norelli; Mohammed Ranavaya; Claudio Terranova; Duarte Nuno Vieira; Guido Viel; Enrique Villanueva; Riccardo Zoia; Giuseppe Sartori
Journal:  Int J Legal Med       Date:  2016-05-04       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.